靶向代谢组学方法探索COVID-19相关ARDS与H1N1流感及细菌性肺炎所致ARDS的差异
该研究对150例患者的血浆样本行靶向代谢组学分析(LC-MS/MS和DI-MS/MS),比较COVID-19、H1N1流感和细菌性肺炎所致ARDS患者与非ARDS COVID-19感染患者及ICU通气对照的代谢表型。结果显示不同感染病因的ARDS之间存在不同的代谢表型:COVID-19相关ARDS与H1N1相关ARDS在牛磺酸和亚牛磺酸、丙酮酸、TCA循环代谢物、赖氨酸和甘油磷脂代谢通路上存在差异;细菌性肺炎相关ARDS与COVID-19相关ARDS在D-谷氨酰胺和D-谷氨酸、精氨酸、脯氨酸、组氨酸和丙酮酸代谢上存在差异。入住ICU的COVID-19 ARDS患者与未入住ICU的COVID-19肺炎患者在苯丙氨酸、色氨酸、赖氨酸和酪氨酸代谢上存在差异。代谢组学分析显示COVID-19 ARDS、H1N1 ARDS和细菌性肺炎ARDS与ICU通气对照之间均存在显著差异,反映潜在的疾病机制可能不同。
要点
- 150例患者血浆靶向代谢组学分析显示,COVID-19、H1N1流感和细菌性肺炎所致ARDS具有不同的代谢表型。
- COVID-19相关ARDS与H1N1相关ARDS的代谢差异涉及牛磺酸和亚牛磺酸、丙酮酸、TCA循环代谢物、赖氨酸和甘油磷脂代谢通路。
- 细菌性肺炎相关ARDS与COVID-19相关ARDS的代谢差异涉及D-谷氨酰胺和D-谷氨酸、精氨酸、脯氨酸、组氨酸和丙酮酸代谢。
- 入住ICU的COVID-19 ARDS患者与未入住ICU的COVID-19肺炎患者在苯丙氨酸、色氨酸、赖氨酸和酪氨酸代谢上存在差异。
- COVID-19 ARDS、H1N1 ARDS和细菌性肺炎ARDS与ICU通气对照之间均存在显著代谢组学差异,反映潜在的疾病机制可能不同。
适用人群与场景
- 3个ARDS队列:COVID-19所致ARDS、H1N1流感所致ARDS、细菌性肺炎所致ARDS,并设非ARDS COVID-19感染患者和ICU通气对照。
研究设计与关键结果
- 研究对总共150例患者的血浆样本使用定量LC-MS/MS和DI-MS/MS分析平台行靶向代谢组学分析。
- 不同感染病因的ARDS之间检测到不同的代谢表型。
- COVID-19相关ARDS与H1N1相关ARDS的代谢组学差异涉及牛磺酸和亚牛磺酸、丙酮酸、TCA循环代谢物、赖氨酸和甘油磷脂代谢通路。
- 细菌性肺炎相关ARDS与COVID-19相关ARDS在D-谷氨酰胺和D-谷氨酸、精氨酸、脯氨酸、组氨酸和丙酮酸代谢上存在差异。
- 入住ICU的COVID-19 ARDS患者与未入住ICU的COVID-19肺炎患者在苯丙氨酸、色氨酸、赖氨酸和酪氨酸代谢上存在差异。
- 代谢组学分析显示COVID-19 ARDS、H1N1 ARDS和细菌性肺炎ARDS与ICU通气对照之间均存在显著差异,反映潜在的疾病机制可能不同。
证据类型、等级与局限
- 局限:原文未报告局限性。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「对床旁实践的改变」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
RATIONALE: Acute respiratory distress syndrome (ARDS) is a life-threatening critical care syndrome commonly associated with infections such as COVID-19, influenza, and bacterial pneumonia. Ongoing research aims to improve our understanding of ARDS, including its molecular mechanisms, individualized treatment options, and potential interventions to reduce inflammation and promote lung repair.
OBJECTIVE: To map and compare metabolic phenotypes of different infectious causes of ARDS to better understand the metabolic pathways involved in the underlying pathogenesis.
METHODS: We analyzed metabolic phenotypes of 3 ARDS cohorts caused by COVID-19, H1N1 influenza, and bacterial pneumonia compared to non-ARDS COVID-19-infected patients and ICU-ventilated controls. Targeted metabolomics was performed on plasma samples from a total of 150 patients using quantitative LC-MS/MS and DI-MS/MS analytical platforms.
RESULTS: Distinct metabolic phenotypes were detected between different infectious causes of ARDS. There were metabolomics differences between ARDSs associated with COVID-19 and H1N1, which include metabolic pathways involving taurine and hypotaurine, pyruvate, TCA cycle metabolites, lysine, and glycerophospholipids. ARDSs associated with bacterial pneumonia and COVID-19 differed in the metabolism of D-glutamine and D-glutamate, arginine, proline, histidine, and pyruvate. The metabolic profile of COVID-19 ARDS (C19/A) patients admitted to the ICU differed from COVID-19 pneumonia (C19/P) patients who were not admitted to the ICU in metabolisms of phenylalanine, tryptophan, lysine, and tyrosine. Metabolomics analysis revealed significant differences between C19/A, H1N1/A, and PNA/A vs ICU-ventilated controls, reflecting potentially different disease mechanisms.
CONCLUSION: Different metabolic phenotypes characterize ARDS associated with different viral and bacterial infections.
参考来源
- Lee CH, Banoei MM, Ansari M, et al. Using a targeted metabolomics approach to explore differences in ARDS associated with COVID-19 compared to ARDS caused by H1N1 influenza and bacterial pneumonia. Crit Care. 2024. PMID: 38414082. doi:10.1186/s13054-024-04843-0
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。